International Travel Rules

Debate between Robert Courts and Ben Spencer

Monday 19th July 2021 Commons Chamber

[Robert Courts]

A number of different points were raised in the hon. Lady’s question. All employers and all workplaces of course have to enforce the law as it stands; Parliament has legislated and that must be enforced, and there are authorities to do that. On covid-safe travel, a lot of detailed guidance has been made available and I would expect everybody to continue to follow it, to keep everybody safe, as indeed they very much are doing. Some travel providers may decide to take steps in addition, such as making a mask a condition of carriage or of entry. I am confident that those assessments that each travel provider undertakes on their premises or in their transport means will enable everybody to travel and to remain safe while they travel.

[Dr Ben Spencer (Runnymede and Weybridge) (Con)]

I very much welcome the fact that fully vaccinated people can now travel to amber countries without having to quarantine on return, but I am disappointed with the change in the situation with France and, in effect, the creation of a new “orange-red” category. It is right that the Government act quickly, and it would have been a disaster if France had become a red country, but new variants are going to keep on coming—that is inevitable—and what the sector, families and travellers need is certainty and predictability. Will my hon. Friend assure me that at the next review certainty and predictability particularly will be looked into, and that the traffic light system will remain a three-pronged one, rather than covering all colours of the rainbow?

[Robert Courts]

I am keen to reassure my hon. Friend that the system we have laid out in the Global Travel Taskforce report—the red, amber, green system—remains in place. A precautionary measure has been taken, for the reasons explained, with regard to France. I agree with him that certainty is what we would like to provide—we aim to do that through the system that we have. One difficulty, of course, is that if a situation develops in another country with regard to a variant or increased prevalence, we have to react to that, and it is right that we do so. In answer to his question as to whether these matters will be kept under review as we continue to consider policy, I can tell him that they will, of course.